Login

Sustainability Spotlight: Joao Bento on CTT Portugal Post | João Bento - CEO of CTT Correios de Portugal, S.A. 00:10:00

Share On Facebook Share On Twitter

João Bento is the CEO of CTT Correios de Portugal, S.A.

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Antony John, CEO of FundQuest UK: Exploring Post-Crisis Investment Strategies and the Role of Fiduciary Management at FundForum Middle East 2010
00:00:00
SkinBioTherapeutics will "continue to be flexible enough to adapt to opportunities" - Stuart Ashman Chief Executive, Skinbiotherapeutics
00:10:00
Generative AI Truly Reshaping Business|Danel Dayan,Venture Capital Investor,Battery Ventures
00:10:00
Fintechs Trillion Dollar Future|Nigel Morris, Managing Partner, QED Investors
00:10:00
Exchange Europe 2023: Carlos Hernandez, Senior Tax Manager | David DeStefano, CEO, Vertex IncVERX:NMQ
00:10:00
PDAC 2024 Recap: 21 Junior Mining Stocks, Dave Lotan's Tips, and Key Takeaways | Jean-Sébastien David - PRESIDENT, CEO AND DIRECTOR of NioBay Metals Inc.
00:10:00
Expert Perspectives on Active ETFs and Market Strategies with Noah Hammond | Noah Hamman, CEO ,  AdvisorShares Investments, LLC.
00:10:00
Early-stage technology venture fund focused on supporting enterprises|Penny Pritzker,Co-Founder,Inspired Capital Partners
00:10:00
LivePerson CEO Robert Locascio discusses with Jim Cramer how conversational AI is transforming the call center industry.
00:10:00
Introduction to Sano Galt: Junior Gold Exploration in Guinea
00:10:00
Strategic Financing and Exploration Plans: A Conversation with North Isle Copper and Gold
00:10:00
Groundbreaking Success | Sam Ataya, Executive, President & Ceo, Western Magnesium Corp

© 2017 - Neuhu+